Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis
Clinical trial NCT05881785 · COMPLETED
Trial details
- NCT number
- NCT05881785
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2023-12-18
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.